These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2526963)

  • 1. Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin.
    Rougier P; Lasser P; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S; Droz JP
    Sel Cancer Ther; 1989; 5(1):47-54. PubMed ID: 2526963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Locoregional chemotherapy of hepatic metastases of colorectal cancer].
    Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
    Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
    Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
    Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer.
    Koks CH; Brouwers JR; Sleijfer DT
    Pharm Weekbl Sci; 1988 Apr; 10(2):69-75. PubMed ID: 2969092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement.
    Oberfield RA; Sampson E; Heatley GJ
    Am J Clin Oncol; 2004 Aug; 27(4):376-83. PubMed ID: 15289731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues.
    Patt YZ
    J Clin Oncol; 1993 May; 11(5):815-9. PubMed ID: 8487044
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional chemotherapy for colorectal liver metastases: thirty years without patient benefit.
    Begos DG; Ballantyne GH
    J Surg Oncol; 1994 Jul; 56(3):139-44. PubMed ID: 8028342
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.
    Oberfield RA; McCaffrey JA; Polio J; Clouse ME; Hamilton T
    Cancer; 1979 Aug; 44(2):414-23. PubMed ID: 157798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM; Byfield JE; Goldfarb PB; Frankel S; Ginn C; Greer S
    Cancer; 1982 Sep; 50(5):850-62. PubMed ID: 6212114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases.
    Heinrich S; Petrowsky H; Schwinnen I; Staib-Sebler E; Gog C; El-Ganainy A; Gutt C; Müller HH; Lorenz M
    Surgery; 2003 Jan; 133(1):40-8. PubMed ID: 12563236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
    J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver.
    Seeger J; Woodcock TM; Blumenreich MS; Richardson JD
    Cancer Invest; 1989; 7(1):1-6. PubMed ID: 2544247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.